BACKGROUND AND AIMS: Physical activity is beneficial in several chronic disorders including Crohn's disease, but the preferred type of exercise is unknown. Our study aimed to examine and compare the safety, feasibility and potential beneficial effects of individual moderate endurance and moderate muscle training in patients with Crohn's disease. METHODS:Quiescent or mildly active (Crohn's disease activity index <220) patients with Crohn's disease were randomly allocated to either a control, endurance, or muscle training group. Participants exercised individually for 3 months three times per week. Endpoints included dropout rate, disease activity, inflammatory parameters including faecal calprotectin, anthropometric data, quality of life, physical activity and strength. RESULTS: A total of 45 patients with Crohn's disease were randomly allocated. In the endurance group (n = 17), the dropout rate was significantly higher (47% vs. 13%) compared with the muscle group (n = 15). In both groups the maximal and average strength in the upper and lower extremities increased significantly (all P < 0.04). In the endurance group emotional function was significantly improved (P = 0.03). Statistically significant changes of disease activity and other outcome parameters were not observed in this pilot cohort. CONCLUSION: Both individual moderate endurance and muscle training can be safely performed in patients with mild or quiescent Crohn's disease. Muscle training appears more feasible and may be favoured. Both forms of exercise have beneficial effects on strength. Quality of life increased in both intervention groups, although statistical significance was only reached in one subgroup.
RCT Entities:
BACKGROUND AND AIMS: Physical activity is beneficial in several chronic disorders including Crohn's disease, but the preferred type of exercise is unknown. Our study aimed to examine and compare the safety, feasibility and potential beneficial effects of individual moderate endurance and moderate muscle training in patients with Crohn's disease. METHODS: Quiescent or mildly active (Crohn's disease activity index <220) patients with Crohn's disease were randomly allocated to either a control, endurance, or muscle training group. Participants exercised individually for 3 months three times per week. Endpoints included dropout rate, disease activity, inflammatory parameters including faecal calprotectin, anthropometric data, quality of life, physical activity and strength. RESULTS: A total of 45 patients with Crohn's disease were randomly allocated. In the endurance group (n = 17), the dropout rate was significantly higher (47% vs. 13%) compared with the muscle group (n = 15). In both groups the maximal and average strength in the upper and lower extremities increased significantly (all P < 0.04). In the endurance group emotional function was significantly improved (P = 0.03). Statistically significant changes of disease activity and other outcome parameters were not observed in this pilot cohort. CONCLUSION: Both individual moderate endurance and muscle training can be safely performed in patients with mild or quiescent Crohn's disease. Muscle training appears more feasible and may be favoured. Both forms of exercise have beneficial effects on strength. Quality of life increased in both intervention groups, although statistical significance was only reached in one subgroup.
Authors: Cora L Craig; Alison L Marshall; Michael Sjöström; Adrian E Bauman; Michael L Booth; Barbara E Ainsworth; Michael Pratt; Ulf Ekelund; Agneta Yngve; James F Sallis; Pekka Oja Journal: Med Sci Sports Exerc Date: 2003-08 Impact factor: 5.411
Authors: Gert Van Assche; Axel Dignass; Julian Panes; Laurent Beaugerie; John Karagiannis; Mathieu Allez; Thomas Ochsenkühn; Tim Orchard; Gerhard Rogler; Edouard Louis; Limas Kupcinskas; Gerassimos Mantzaris; Simon Travis; Eduard Stange Journal: J Crohns Colitis Date: 2010-01-15 Impact factor: 9.071
Authors: Peter Klare; Johanna Nigg; Johannes Nold; Bernhard Haller; Anne B Krug; Sebastian Mair; Christoph K Thoeringer; Jeffrey W Christle; Roland M Schmid; Martin Halle; Wolfgang Huber Journal: Digestion Date: 2015-03-24 Impact factor: 3.216
Authors: Katrin Stuecher; Claus Bolling; Lutz Vogt; Daniel Niederer; Katharina Schmidt; Axel Dignaß; Winfried Banzer Journal: Support Care Cancer Date: 2018-10-04 Impact factor: 3.603
Authors: Ersilia M DeFilippis; Saniya Tabani; Ryan U Warren; Paul J Christos; Brian P Bosworth; Ellen J Scherl Journal: Dig Dis Sci Date: 2015-08-09 Impact factor: 3.199
Authors: D R van Langenberg; P Della Gatta; S A Warmington; D J Kidgell; P R Gibson; A P Russell Journal: J Crohns Colitis Date: 2013-08-12 Impact factor: 9.071
Authors: Alberto J Alves; João L Viana; Suiane L Cavalcante; Nórton L Oliveira; José A Duarte; Jorge Mota; José Oliveira; Fernando Ribeiro Journal: World J Cardiol Date: 2016-10-26